309 related articles for article (PubMed ID: 31478912)
1. The supply chain of human pancreatic β cell lines.
Scharfmann R; Staels W; Albagli O
J Clin Invest; 2019 Sep; 129(9):3511-3520. PubMed ID: 31478912
[TBL] [Abstract][Full Text] [Related]
2. Distinctions between the islets of mice and men: implications for new therapies for type 1 and 2 diabetes.
Levetan CS; Pierce SM
Endocr Pract; 2013; 19(2):301-12. PubMed ID: 23186955
[TBL] [Abstract][Full Text] [Related]
3. How to make insulin-producing pancreatic β cells for diabetes treatment.
Lu J; Xia Q; Zhou Q
Sci China Life Sci; 2017 Mar; 60(3):239-248. PubMed ID: 27796637
[TBL] [Abstract][Full Text] [Related]
4. Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.
Fändrich F; Ungefroren H
Adv Exp Med Biol; 2010; 654():641-65. PubMed ID: 20217518
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic stem cells remain unresolved.
Jiang FX; Morahan G
Stem Cells Dev; 2014 Dec; 23(23):2803-12. PubMed ID: 25132582
[TBL] [Abstract][Full Text] [Related]
6. Regenerative medicine for diabetes: differentiation of human pluripotent stem cells into functional β-cells in vitro and their proposed journey to clinical translation.
Bose B; Katikireddy KR; Shenoy PS
Vitam Horm; 2014; 95():223-48. PubMed ID: 24559920
[TBL] [Abstract][Full Text] [Related]
7. Lipids and immunoinflammatory pathways of beta cell destruction.
Imai Y; Dobrian AD; Morris MA; Taylor-Fishwick DA; Nadler JL
Diabetologia; 2016 Apr; 59(4):673-8. PubMed ID: 26868492
[TBL] [Abstract][Full Text] [Related]
8. Human beta cell mass and function in diabetes: Recent advances in knowledge and technologies to understand disease pathogenesis.
Chen C; Cohrs CM; Stertmann J; Bozsak R; Speier S
Mol Metab; 2017 Sep; 6(9):943-957. PubMed ID: 28951820
[TBL] [Abstract][Full Text] [Related]
9. Gene and cell therapies for diabetes mellitus: strategies and clinical potential.
Giannoukakis N; Robbins PD
BioDrugs; 2002; 16(3):149-73. PubMed ID: 12102644
[TBL] [Abstract][Full Text] [Related]
10. In Vivo Visualization of β-Cells by Targeting of GPR44.
Eriksson O; Johnström P; Cselenyi Z; Jahan M; Selvaraju RK; Jensen-Waern M; Takano A; Sörhede Winzell M; Halldin C; Skrtic S; Korsgren O
Diabetes; 2018 Feb; 67(2):182-192. PubMed ID: 29208633
[TBL] [Abstract][Full Text] [Related]
11. Lineage Reprogramming: A Promising Road for Pancreatic β Cell Regeneration.
Wei R; Hong T
Trends Endocrinol Metab; 2016 Mar; 27(3):163-176. PubMed ID: 26811208
[TBL] [Abstract][Full Text] [Related]
12. Mast Cells and the Pancreas in Human Type 1 and Type 2 Diabetes.
Masini M; Suleiman M; Novelli M; Marselli L; Marchetti P; De Tata V
Cells; 2021 Jul; 10(8):. PubMed ID: 34440644
[TBL] [Abstract][Full Text] [Related]
13. Harnessing CXCL12 signaling to protect and preserve functional β-cell mass and for cell replacement in type 1 diabetes.
Alagpulinsa DA; Cao JJL; Sobell D; Poznansky MC
Pharmacol Ther; 2019 Jan; 193():63-74. PubMed ID: 30149101
[TBL] [Abstract][Full Text] [Related]
14. Towards a Functional Cure for Diabetes Using Stem Cell-Derived Beta Cells: Are We There Yet?
Bourgeois S; Sawatani T; Van Mulders A; De Leu N; Heremans Y; Heimberg H; Cnop M; Staels W
Cells; 2021 Jan; 10(1):. PubMed ID: 33477961
[TBL] [Abstract][Full Text] [Related]
15. Concise Review: Macrophages: Versatile Gatekeepers During Pancreatic β-Cell Development, Injury, and Regeneration.
Van Gassen N; Staels W; Van Overmeire E; De Groef S; Sojoodi M; Heremans Y; Leuckx G; Van de Casteele M; Van Ginderachter JA; Heimberg H; De Leu N
Stem Cells Transl Med; 2015 Jun; 4(6):555-63. PubMed ID: 25848123
[TBL] [Abstract][Full Text] [Related]
16. Insulin-secreting cells derived from stem cells: clinical perspectives, hypes and hopes.
Roche E; Reig JA; Campos A; Paredes B; Isaac JR; Lim S; Calne RY; Soria B
Transpl Immunol; 2005 Dec; 15(2):113-29. PubMed ID: 16412956
[TBL] [Abstract][Full Text] [Related]
17. Amyloid formation reduces protein kinase B phosphorylation in primary islet β-cells which is improved by blocking IL-1β signaling.
Zhang Y; Warnock GL; Ao Z; Park YJ; Safikhan N; Ghahary A; Marzban L
PLoS One; 2018; 13(2):e0193184. PubMed ID: 29474443
[TBL] [Abstract][Full Text] [Related]
18. Beta Cell Imaging-From Pre-Clinical Validation to First in Man Testing.
Demine S; Schulte ML; Territo PR; Eizirik DL
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019671
[TBL] [Abstract][Full Text] [Related]
19. Histology of Type 1 Diabetes Pancreas.
Willcox A; Gillespie KM
Methods Mol Biol; 2016; 1433():105-17. PubMed ID: 26801316
[TBL] [Abstract][Full Text] [Related]
20. A shared comparison of diabetes mellitus and neurodegenerative disorders.
Morsi M; Maher A; Aboelmagd O; Johar D; Bernstein L
J Cell Biochem; 2018 Feb; 119(2):1249-1256. PubMed ID: 28681964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
